First Citizens Financial Corp Amgen Inc Transaction History

First Citizens Financial Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	SELL	$229.03 - $291.01 $251,933 - $320,111	-1,100 Reduced 55.92%	867 $228,000
Q3 2022 Oct 12, 2022	SELL	$224.46 - $253.15 $22,446 - $25,315	-100 Reduced 4.84%	1,967 $443,000
Q2 2022 Jul 08, 2022	SELL	$230.71 - $256.74 $9,920 - $11,039	-43 Reduced 2.04%	2,067 $503,000
Q4 2021 Jan 13, 2022	SELL	$198.88 - $227.6 $3,977 - $4,552	-20 Reduced 0.94%	2,110 $475,000
Q3 2021 Oct 14, 2021	SELL	$212.27 - $248.7 $19,104 - $22,383	-90 Reduced 4.05%	2,130 $453,000
Q1 2021 Apr 09, 2021	SELL	$221.91 - $258.6 $10,207 - $11,895	-46 Reduced 2.03%	2,220 $552,000
Q4 2020 Feb 01, 2021	BUY	$216.38 - $257.67 $43,276 - $51,534	200 Added 9.68%	2,266 $521,000
Q2 2020 Jul 30, 2020	SELL	$197.81 - $242.74 $6,923 - $8,495	-35 Reduced 1.67%	2,066 $487,000
Q1 2020 Apr 27, 2020	SELL	$182.24 - $241.7 $7,471 - $9,909	-41 Reduced 1.91%	2,101 $426,000
Q4 2019 Jan 21, 2020	BUY	$189.21 - $243.2 $405,287 - $520,934	2,142 New	2,142 $516,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $151B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of First Citizens Financial Corp, based on Form 13F filings with the SEC.

Stay updated on First Citizens Financial Corp with notifications on news.